PALISADE CAPITAL MANAGEMENT, LP - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 184 filers reported holding CLOVIS ONCOLOGY INC in Q2 2015. The put-call ratio across all filers is 1.20 and the average weighting 0.6%.

Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q1 2020$102,000
-30.1%
16,000
+14.3%
0.00%0.0%
Q4 2019$146,000
+105.6%
14,000
-22.7%
0.00%
+100.0%
Q3 2019$71,000
-98.9%
18,100
-74.5%
0.00%
-99.0%
Q3 2015$6,523,000
+1250.5%
70,937
+1189.8%
0.19%
+1500.0%
Q2 2015$483,0005,5000.01%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q2 2015
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 150,000$1,564,0004.60%
Healthcare Value Capital, LLC 100,000$1,043,0003.07%
Palo Alto Investors LP 5,056,286$52,712,0002.90%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 1,328,200$13,848,0001.53%
Ikarian Capital, LLC 513,700$5,355,0000.87%
Pinz Capital Management, LP 207,800$2,166,0000.79%
Leap Investments LP 146,300$1,525,0000.72%
Elk Creek Partners, LLC 574,616$5,990,0000.69%
SECTOR GAMMA AS 408,625$4,260,0000.68%
Artal Group S.A. 1,000,000$10,425,0000.40%
View complete list of CLOVIS ONCOLOGY INC shareholders